Renal Diseases

Classifying Renal Diseases

Pre-renal:

▪ Any process that decreases renal blood flow

Renal:

▪ Glomerular disease:

Spectrum ranging from glomerulonephritis to nephrotic syndrome

▪ Tubular-interstitial disease:

– Acute tubular necrosis (ATN):

o Ischemic

o Nephrotoxic insult

– Acute interstitial nephritis

▪ Vascular disease:

– Vascular occlusion – renal artery/vein thrombosis, thrombotic microangiopathies (TTP, HUS, HSP)

– Intrarenal vasculitis – e.g. Wegener granulomatosis

Post-renal:

▪ Any process that obstructs urine outflow

Urinary Tract Obstruction

▪ Interference with urine flow within the urinary tract

▪ Also known as “obstructive uropathy”

Etiology:

▪ May be anatomic or functional obstruction, including:

– Compression by tumors

o E.g. kidneys, bladder, uterus, colon

– Compression by enlarged prostate, or prolapsed pelvic organ

– Pelvic adhesions (retroperitoneal fibrosis)

– Stones

– Strictures due to inflammation/scarring of walls

▪ Sites of obstructions:

– Obstruction can occur anywhere in the pathway of urine flow

– Effects depend on the site, cause and degree of obstruction

Pathophysiology & Complications:

▪ Dilation proximal to site of obstruction

– Hydronephrosis

o Dilation of renal pelvis & calyces

– Hydroureter

o Dilation of ureter

– Compensatory hypertrophy & urine accumulation

– Tubular and later glomerular damage if obstruction is not relieved

Clinical manifestations:

▪ Difficulty to void, decreased urine output

▪ Slowed stream, “dribble”

▪ Urgency especially at night

▪ False sense of fullness

▪ Blood in the urine

▪ Severity of manifestations will depend on:

– Location

– Degree

– Unilateral versus bilateral

– Upper versus lower urinary tract

– Duration and cause of obstruction

Kidney Stones

▪ Masses of crystals, protein, or other substances that form within the kidney and may obstruct the urine flow

Etiology & risk factors:

▪ Gender & race

▪ Dietary pattern

▪ Fluid intake

▪ Geographic location; temp, humidity, rainfall

▪ Seasonal factors

▪ Occupation

Pathophysiology:

▪ Salt supersaturation

▪ Precipitation of a salt from liquid to solid state

▪ Crystallization: growth from a nucleus into a stone

▪ Factors affecting stone formation and crystallization:

– Temperature

– pH

– Organic material

– Influence of additional substances:

o Tamm-Horsfall protein (a crystal growth-inhibiting substance)

Classification of stones:

▪ Calcium oxalates/phosphate are most common (70-80%)

▪ Magnesium/ammonium phosphate

▪ Uric acid stones

▪ Stones < 5mm will likely be excreted via urine, while those > 1cm will not

Clinical manifestations & Diagnosis

▪ Renal colic:

– Moderate to severe spasms of pain originating in flank, radiating to groin

▪ May have associated nausea, vomiting

▪ Urinary urgency and frequency

▪ Diagnostic testing includes:

– Urine analysis

o Hematuria is an indicator of stones

– Imaging (x-ray, ultrasound, and/or computed tomography)

o Kidney, ureter, bladder

Neurogenic Bladder

▪ Bladder dysfunction caused by neurogenic disorders (brain, spinal cord, peripheral nerve) interfering with micturition

Etiology:

▪ Multiple of neurologic disorders including:

– Parkinson’s disease

– Multiple sclerosis (MS)

– Infection of the brain or spinal cord

– CVA

– Peripheral neuropathies

– Pelvic surgery

– Congenital (I.e. spina bifida)

Pathophysiology:

▪ Lesions in brain centers or the spinal cord

▪ Upper or lower motor neuron lesions impacting the ability to control micturition thus leading to overactive or underactive bladder syndrome

Clinical manifestations:

▪ Frequency, urgency, nocturia

▪ Retention with overflow

▪ Stress incontinence

Renal Tumors- Renal Cell Carcinoma

▪ Malignant tumor (adenocarcinoma) originating from tubular epithelium

▪ Most common in males > 60 years

▪ 25% present with metastasis, including to lung, liver, bone, and lymph nodes

Clinical manifestations:

▪ Usually presents in advanced cases

▪ Dull aching flank pain

▪ Mass

▪ Hematuria

Renal Tumors- Wilm’s Tumor

▪ A common childhood cancer

– Prevalence in children 2-4 years old

▪ Mostly unilateral

Clinical Presentation:

– Abdominal swelling/ mass

– Pain

– Hematuria

Urinary Tract Infection (UTI)

▪ Inflammation of urinary epithelium mostly due to infection

▪ Most common pathogen:

– Escherichia coli

Lower UTI (cystitis/urethritis):

– Inflammation of the bladder (cystitis) and/or urethra (urethritis)

▪ Clinical manifestations:

– Frequency

– Dysuria

– Urgency

– Lower abdominal and/or suprapubic pain

Upper UTI (pyelonephritis):

– Infection of kidney and renal pelvis

▪ Risk/ predisposing factors:

– Vesicoureteral reflux

– Urinary tract obstruction

– Previous pyelonephritis

– Immunocompromised state

▪ Common pathogens:

– E. coli, Proteus, Pseudomonas

▪ Pathophysiology:

o Ascending infection from lower UTI

o Persistent or recurring episodes of acute pyelonephritis

o Scarring, further kidney damage & renal failure

▪ Additional considerations

– What is the overall clinical condition or associated comorbidity?

– Is a lab diagnosis available?

– Is the person pregnant and are there complications?

Glomerulonephritis

▪ Inflammation/damage of the glomeruli

Etiology/Forms:

▪ Immune injury (most common):

– Post-streptococcal glomerulonephritis:

o Most common cause of hematuria in children

o Several weeks following infection with group A Streptococci

o Immune complex deposition in glomeruli (Type III hypersensitivity)

– IgA nephropathy (Berger’s disease):

o A common cause/type of glomerulonephritis world wide

o Common between late teens and late 30s and runs in families

o IgA deposition in glomeruli (Type II hypersensitivity)

– Good Pasture syndrome:

o Develops one week following upper respiratory tract infection (URTI)

o Pathological Triad:

1. Anti-GBM antibodies

2. Rapidly progressive glomerulonephritis

3. Pulmonary hemorrhage

▪ Non-immune injury:

– Drugs

– Toxins

– Ischemia

o Vasculitis (E.g. Wegener granulomatosis)

▪ Secondary to systemic diseases:

– SLE (Lupus nephritis)

– DM (Kimmelstiel–Wilson nodules is a histopathological finding)

– Amyloid

– HTN

Pathophysiology:

▪ Glomerular inflammation (review pathology of inflammation)

▪ Rapidly progressive

Clinical manifestations:

▪ Hematuria with red cell casts

▪ Edema

▪ Oliguria

▪ Hypertension

▪ Low grade fever, flank pain

Diagnosis

▪ Clinical presentation

▪ Renal biopsy (invasive technique) but confirms pathological form and guides treatment

Complications:

▪ Can proceed to nephrotic syndrome

Nephrotic Syndrome

▪ A syndrome whereby a glomerular lesion leads to massive protein loss

Etiology:

▪ Diabetes mellitus and hypertension are the most common causes for nephrotic syndrome

▪ Glomerulonephritis

▪ Others:

– Amyloidosis

– Cancer

– Drugs

– SLE

– HIV

Types (histo-pathophysiological):

▪ Minimal change disease

– Mainly children, NSAIDs

▪ Membranous glomerulonephritis

– Adults, NSAIDs, cancer

▪ Focal segmental glomerulosclerosis

– HIV patients

Pathophysiology and clinical manifestations:

▪ Glomerular injury that leads to protein leakage

▪ Proteinuria: ≥3.5 g of protein in urine/ day

▪ Hypoalbuminemia: <3 gm/dL

▪ Edema

– May be periorbital, generalized and/or pitting

▪ Hyperlipidemia, lipiduria

– Hyperlipidemia occurs from decreased protein levels

– Proteins are required in the form of lipoproteins for the uptake of lipids into tissue

– Absence of proteins leads to build-up of lipids in the blood

▪ Hypogammaglobulinemia

▪ Vitamin D deficiency

▪ Hypercoagulable state

▪ Manifestations of RAAS stimulation

Acute Kidney Injury (AKI)

▪ Sudden decline of kidney function

– Occurs on a spectrum ranging from minimal changes in kidney function to kidney failure requiring dialysis and kidney transplant

▪ Failure of kidney function means:

– Reduction of glomerular filtration and creatinine clearance →

– Accumulation of nitrogenous waste in blood →

– Encephalopathy and impairment of brain function (uremia and high creatinine).

Stages of AKI:

Renal insufficiency:

– Decline kidney functions by 25% of normal (GFR~ 25-30mL/min)

– Mild elevation of serum creatinine

Renal failure:

– Significant loss of kidney function, requiring dialysis

End stage renal failure (ESRF; uremia):

– Renal function is less than 10%, requiring dialysis

Etiology & pathophysiology:

▪ AKI can originate from causes before (pre-renal), within (intrarenal), or after (post-renal) the kidney

▪ Pre-renal causes are occurred before the kidney and are due to impaired renal perfusion

– The most common causes for AKI, including:

o Hypovolemia:

1. Hemorrhage (E.g. trauma, GI bleeding, childbirth)

2. Loss of plasma volume (E.g. Burns)

3. Loss of water/electrolytes (E.g. Severe vomiting, diarrhea, intestinal obstruction, diuretic overuse)

o Hypotension/ Systemic vasodilation (E.g. Shock, CHF, massive pulmonary embolism)

o Cirrhosis through the process of ↓ albumin → ↓ colloid oncotic pressure → ↓ intravascular volume

▪ Intra-renal: Causes from within the kidney and include renal parenchymal and interstitial disorders

– Acute tubular necrosis (ATN) is the most common

o Causes for ATN include:

1. Ischemic: E.g. Post-operative ischemia, sepsis

2. Toxic: E.g. Drugs, antibiotics eg gentamicin

3. Crystals/pigments: E.g. Uric acid, oxalates, myoglobin, hemoglobin

▪ Post-renal: AKI originating after the kidney, and the most rare

– Obstructive uropathy: E.g. Enlarged prostate, bladder stones, uretheral, ureteric (bilateral)

Clinical manifestations:

– Oliguria in various levels

– Manifestation of underlying pathology

Pathogenesis & Stages:

1. Initiation phase (first 36h)

– Kidney injury is evolving with slight decrease in urine output and increase in blood urea nitrogen (BUN)

– Prevention of injury is possible

2. Maintenance phase

– Established kidney injury and dysfunction

– Sustained oliguria (40-400mL/day)

– Increase in ECF volume → can be associated with edema, pulmonary congestion

– Hyperkalemia may be present leading to EKG changes and increased risk of sudden death

– Metabolic acidosis

3. Recovery phase (2-3 weeks)

– Brisk diuresis (up to 3L/day) leading to urinary loss of electrolytes Ca, K, PO4

– Hypokalemia (one of most serious complications of recovery) leading to EKG changes and presenting a risk for cardiac arrhythmias

– Renal function eventually recovers with BUN and serum creatinine returning to baseline

Chronic Kidney Disease (CKD)

▪ Chronic progressive loss of renal function

▪ CKD is defined as glomerular filtration rate (GFR) < 60 mL/ min/1.73 m2, for 3 months or more irrespective of cause

Etiology:

▪ Systemic diseases:

– E.g. Hypertension and Diabetes mellitus

▪ Intrinsic kidney disease:

– Glomerular or tubular

– Glomerulonephritis

– Pyelonephritis

– Obstructive uropathy

Stages:

▪ Normal Kidney Function: GFR >90mL/min

▪ Mild: GFR 60-89mL/min

▪ Moderate: GFR 30-59mL/min

▪ Severe: GFR 15-29mL/min

▪ End stage: GFR <15mL/min (regular dialysis or transplantation)

Pathophysiology:

▪ Continued loss of functioning nephrons

▪ Glomerular hypertrophy and adaptive hyperfiltration

▪ Proteinuria and glomerulosclerosis

▪ RAAS activation and increased Angiotensin II leading to glomerular and systemic hypertension

▪ Erythropoietin deficiency

▪ Kidney unable to excrete potassium (K), Phosphate (PO4), Magnesium (Mg)

▪ Tubulointerstitial inflammation and fibrosis

Clinical manifestations:

▪ Manifestations of uremia

▪ All systems are affected:

– Reduced GFR, increased plasma creatinine, BUN

– Increased sodium and water retention leading to edema and hypertension

– Metabolic acidosis when GFR 30-40%

– Bone change and subsequent fractures

– Proteinuria and impaired fat and carbohydrate metabolism

– Hypertension, CHF, edema

– Pulmonary edema, Kussmaul respiration

– Anemia, hypercoagulability & bleeding

– Increased risk of infection

– Uremic encephalopathy

– Peripheral neuropathy

– Impaired sexual/reproductive functions (anovulation, erectile dysfunction)

– Pruritus, sallow skin color

Thrombotic microangiopathies

▪ Vascular kidney lesions where thrombosis is common

▪ Characterized by a “ thrombotic” triad of symptoms:

1. Thrombocytopenia & Purpura

2. Hemolytic anemia

3. Renal damage / failure

▪ A common cause of acute renal failure

▪ Two common conditions, each exhibit additional different pathologies:

1. Hemolytic Uremic Syndrome

2. Thrombotic Thrombocytopenic

Hemolytic-Uremic Syndrome (HUS)

Etiology:

– Infections

i. Bacterial:

• E coli; O:157 H:7

• Shiga toxins (secreted by this E coli strain; names after Shigella shiga toxin as it has similar effect) causing damage to the blood vessel (endothelium/RBCs)

ii. Viral infection

Pathophysiology

– Thrombotic Triad

– Glomerular damage

o Cell swelling

o Blood vessel occlusion with fibrin clots

– Acute hemolytic anemia (schistocytes seen in peripheral blood smear)

– Splenomegaly

– Thrombi in microcirculation including renal vasculature

Clinical manifestations

– Sudden onset of pallor, bruising or purpura, irritability, and oliguria

– Slight fever

– Anorexia

– Vomiting

– Diarrhea

o Stool is watery and blood stained

– Abdominal pain, mild jaundice (due to hemolysis)

– Renal failure is apparent within the first few days, causing:

o Metabolic acidosis

o Hyperkalemia

o Hypertension

Thrombotic Thrombocytopenic Purpura (TTP)

Etiology & Pathophysiology:

– Thrombotic Triad

– Deficiency in ADAMTS13 enzyme

o ADAMTS13 is responsible for cleavage of large multimers of VWF (von Willebrand factor) protein

o VWF is protein, which has two critical

roles in coagulation cascade and clot formation at the site of injury

• VWF is a sticky multimeric protein which binds platelet and injured subendothelium to create thrombus at site of injury.

o VWF is a carrier for FVIII and protects it from proteolytic cleavage

o The deficiency in ADAMTS13 enzyme → elevated levels of VWF large multimers → thrombosis

– Genetic mutations

Clinical manifestations:

– Differentiating features from HUS would be neurologic complications:

o Recurrent symptomatic episodes including seizures and vision loss

– Lab features:

o Serum ADMTS 13

o Serum VWF